Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial.
Teoh JY, Cheng CH, Tsang CF, Kai-Man Li J, Kwun-Chung Cheng B, Hoi-Chak Chan W, Kwun-Wai Chan W, Churk-Fai Li T, Chiu Y, Law MC, Lok-Hei Leung C, Sze-Ho Ho B, Yue-Kit Lee C, Cheong-Kin Chan R, Shu-Yin Chan E, Chan MT, Hok-Leung Tsu J, Tam HM, Lam KM, So HS, Cho CL, Ng CM, Chan CK, Liu PL, Wing-Hong Chu R, Tsui-Lin Ng A, Chu SK, Yee CH, Yiu MK, Lo KL, Au WH, Ma WK, Ka-Fung Chiu P, Sze-Wan Kwok H, Yip SY, Leung CH, Ng CF; EB-StaR Study Group.
Eur Urol. 2024 Aug;86(2):103-111. doi: 10.1016/j.eururo.2024.04.015. Epub 2024 Apr 30.
Monopolar versus bipolar transurethral resection of bladder Tumour: post-hoc analysis of a prospective trial.
Wong CH, Lim JY, Ko IC, Leung DK, Yuen SK, Yip SY, Ng CF, Teoh JY, Chan ES.
World J Urol. 2024 Aug 2;42(1):466. doi: 10.1007/s00345-024-05124-9.
An updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor.
Xu Z, Wang Q, Li B, Hao X, Ren C, Chen X, Liu L, Liu X.
Int J Surg. 2025 Apr 1;111(4):3061-3077. doi: 10.1097/JS9.0000000000002291.
Efficacy and safety of 2-micron laser versus conventional trans-urethral resection of bladder tumor for non-muscle-invasive bladder tumor: A systematic review and meta-analysis.
Gu J, He Z, Chen Z, Wu H, Ding M.
J Cancer Res Ther. 2022 Dec;18(7):1894-1902. doi: 10.4103/jcrt.jcrt_608_22.
Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
Zhou L, Liang X, Zhang K.
Aging Male. 2020 Dec;23(5):1182-1193. doi: 10.1080/13685538.2020.1718637. Epub 2020 Feb 5.
Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
Yang H, Lin J, Gao P, He Z, Kuang X, Li X, Fu H, Du D.
Urol Int. 2020;104(5-6):402-409. doi: 10.1159/000503734. Epub 2020 Jan 7.
Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.
Guigui A, Basile G, Zattoni F, Gallioli A, Verri P, Aumatell J, Gondran-Tellier B, Lechevallier E, Bastide C, Uleri A, Sica M, Long-Depaquit T, Dinoi G, Moro FD, Akiki A, Toledano H, Rajwa P, Montorsi F, Amparore D, Porpiglia F, Breda A, Moschini M, Baboudjian M.
World J Urol. 2024 Aug 12;42(1):480. doi: 10.1007/s00345-024-05192-x.
Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
Ayati M, Amini E, Shahrokhi Damavand R, Nowroozi MR, Soleimani M, Ranjbar E, Nowroozi A.
Urol J. 2019 May 5;16(2):152-156. doi: 10.22037/uj.v0i0.4670.
Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
Lee K, Jeong SH, Yoo SH, Ku JH.
Investig Clin Urol. 2022 Jan;63(1):14-20. doi: 10.4111/icu.20210314.
Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
Kim DH, Choi MS, Choi JH, Lee C, Jeh SU, Kam SC, Hwa JS, Hyun JS, Choi SM.
Investig Clin Urol. 2024 May;65(3):279-285. doi: 10.4111/icu.20230284.
